CMT Research Foundation Advisors

Kim Hunter-Schaedle, Ph.D.

Scientific Consultant

Kim Hunter-Schaedle is a neurobiologist and non-profit research administrator. She trained as a laboratory neurobiologist, earning her Ph.D. at King’s College London, then worked as a research scientist at St. Georges Hospital in London, The Rockefeller University in New York City, and Ontogeny, Inc. she then moved into non-profit research administration. At the Juvenile Diabetes Research Foundation, she headed the diabetes complications grant portfolio. As well as overseeing funding in neuropathy, retinopathy, nephropathy and vascular disease, she managed a glucose sensors research collaboration with the Department of the Army and a retinopathy telemedicine initiative with the National Eye Institute.

After a short stint in technology transfer with Columbia University Science & Technology Ventures, Hunter-Schaedle served as the first Chief Scientific Officer of the Children’s Tumor Foundation, designing and launching a transformative research program portfolio to advance therapeutic development for the rare disease neurofibromatosis. She then joined the Austen Riggs Center, a private residential psychiatric hospital serving as Chief of Staff, then as IRB Administrator.

Hunter-Schaedle has provided expert research operations guidance and services to the Melanoma Research Alliance, Breakthrough Type 1 Diabetes (formerly JDRF), the Avon Foundation, the William Guy Forbeck Research Foundation, the Neurofibromatosis Network and the Lupus Research Alliance.